Chad vs Gambia: Antiretroviral therapy coverage for PMTCT
Chad
77.0%
in 2024
Gambia
77.0%
in 2024
Chad rank
46th
Gambia rank
46th
Antiretroviral therapy coverage for PMTCT over time
- Chad
- Gambia
How they compare
Chad currently reports 77.0% against 77.0% in Gambia, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Gambia ahead.
Chad ranks 46th and Gambia ranks 46th of 84 countries.
Across the 3 decades both report, Chad averaged higher in 1 and Gambia in 2.
Head to head by decade
| Decade | Chad | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.6% | 11.6% | 9.0% | Gambia |
| 2010s | 51.0% | 63.1% | 12.1% | Gambia |
| 2020s | 80.0% | 73.2% | 6.8% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Chad or Gambia?
- Chad, at 77.0% against 77.0% in Gambia as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Chad and Gambia?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Gambia?
- 25 years are reported by both, from 2000 to 2024.
- How do Chad and Gambia rank globally for antiretroviral therapy coverage for pmtct?
- Chad ranks 46th and Gambia ranks 46th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).